I actually really liked everything in this report, albeit most of it in regards to being forward looking.
Costs actually down, which is impressive considering the production issues.
The recent downgrade will hopefully prove... too harsh.
We should see further cost reductions (though not large).
Looks like Nightfall is going to provide some real upside in the near term (with higher grades and more ore).
Already starting to see that Bluebird U/G might have upside for FY2025
Oh how long have I been banging on about the potential of Great Fingal remnant ore....
From an old post of mine, WGX used to include information about Great Fingall having the potential for ore outside of the current mine plan.
Looks to be a real possibility of Great Fingal adding to FY25, outside of what they had already planned.
Finally going to see real exploration (versus just lots of infill (which is important, but.... boring)).
I am starting to feel like even with the large non-sustaining capex to come this quarter and exploration, the spot price to be received by WGX will more than balance it out. All the capital WGX is investing right now is going to be paying for itself in FY2025.
Hopefully the market starts to realise that FY24 was a mixed year, with FY25 being more profitable and production around 250k+ (as a minimum).
- Forums
- ASX - By Stock
- Ann: March Quarter FY24 Investor Update
I actually really liked everything in this report, albeit most...
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WGX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.15 |
Change
0.010(0.47%) |
Mkt cap ! $1.018B |
Open | High | Low | Value | Volume |
$2.15 | $2.17 | $2.11 | $5.897M | 2.745M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 23082 | $2.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.17 | 146091 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 23082 | 2.150 |
4 | 82508 | 2.130 |
4 | 37956 | 2.120 |
6 | 56417 | 2.110 |
6 | 29448 | 2.100 |
Price($) | Vol. | No. |
---|---|---|
2.170 | 146091 | 8 |
2.180 | 112094 | 5 |
2.190 | 6048 | 1 |
2.200 | 44002 | 4 |
2.210 | 31435 | 5 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
$2.14 |
  |
Change
0.010 ( 0.41 %) |
|||
Open | High | Low | Volume | ||
$2.16 | $2.17 | $2.11 | 758059 | ||
Last updated 15.59pm 06/05/2024 ? |
Featured News
WGX (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online